NCT06386679View on ClinicalTrials.gov

Amniotic Fluid Mesenchymal Stem Cells Developed for Chondrogenic Treatment (AFCC) Injection in Elderly Knee Osteoarthritis Patients

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

November 23, 2023

Study Completion Date

March 31, 2025

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

allogenic amniotic fluid mesenchymal stem cell

Intra-articular AFCC injection will be given for single knee for each patient in single dose, 20 million of AFCC in each dose

Trial Locations (1)

10700

Siriraj Hospital, Bangkok Noi

All Listed Sponsors
lead

Siriraj Hospital

OTHER